ICMR approval for HiMedia-Syngene COVID-19 antibody test kit, ELISafe 19TM

ICMR approval for HiMedia-Syngene COVID-19 antibody test kit, ELISafe 19TM     HiMedia Laboratories, a bioscience company with expertise in media manufacturing and diagnostics, and Syngene International, an integrated research and development services company, have collaborated to manufacture ELISafe 19TM, an IgG based ELISA test kit for COVID-19 now approved by the Indian Council of Medical Research (ICMR). The ELISafe 19TM antibody test kit has a sensitivity of 100% and specificity of 99%.   Commenting on the news, Dr. Vishal G. Warke, Director R&D, Cell Culture and Immunology, HiMedia Laboratories,…

Read More

Biocon Biologics Receives DCGI Approval for Emergency Use of CytoSorb® to Treat Critical COVID-19 Patients

Biocon Biologics Receives DCGI Approval for Emergency Use of CytoSorb® to Treat Critical COVID-19 Patients   U.S. FDA recently approved CytoSorb for emergency use in COVID19 patients BIOCON, an innovation-led global biopharmaceuticals company, announced today that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb® to reduce pro-inflammatory cytokines levels in confirmed COVID-19 patients admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. Biocon Biologics has been granted licence for emergency use of…

Read More

Lincoln Pharmaceuticals receives approval to manufacture Hydroxychloroquine and Hydroxychloroquine Sulfate Tablets to fight COVID 19

Lincoln Pharmaceuticals receives approval to manufacture Hydroxychloroquine and Hydroxychloroquine Sulfate Tablets to fight COVID 19     Lincoln Pharmaceuticals Limited (“Lincoln Pharma”), one of India’s leading healthcare companies hasreceived approval to manufacture Hydroxychloroquine (HCQ) among other critical drugs to fight COVID 19. Company received approval from Food & Drug Control Administration, Gujarat to manufacture varied dosages of Hydroxychloroquine Tablets and Hydroxychloroquine Sulfate Tablets among others at its plant in Khatraj in Ahmedabad.  After necessary approval from Directorate General of Foreign Trade (DGFT) company will be able to export these products.…

Read More

Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19)

Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19)     Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has initiated an accelerated research programme with multiple teams in India and Europe developing a vaccine for the novel coronavirus, 2019-nCoV (COVID-19) based on two approaches. The first approach deals with development of a DNA vaccine against the major viral membrane protein responsible for the cell entry of the novel coronavirus, now called COVID-19. The plasmid DNA would be introduced into the…

Read More